Additionally, HNSCC samples with top 30% LIF expression harbored differentially expressed genes enriched in CSCs‐related signatures including KRAS signaling and EMT as compared to those with bottom 30% LIF expression (Figure S14B, Supporting Information). This evidence concerns the gene KRAS and head and neck squamous cell carcinoma.